European nutraceuticals market expected to be worth US$415.32m by 2018, says new report
Growth will be led by dietary supplements owing to a significant ageing population in the region
The amino-acids, peptides and proteins market in Europe is expected to grow at a CAGR of 6.1% from around US$291.49m in 2012 to $415.32m by 2018, according to a new report from MicroMarket Monitor, to be published in September.
As well as in-depth analysis, the report, Europe Amino-acids, Peptides & Proteins, will provide a glimpse of the segmentation in the market, and is supported by various tables and figures.
Europe has a significant ageing population, which means that dietary supplements is the largest application segment. Nutraceuticals ingredient manufacturers are constantly expanding their production capabilities to meet demand for nutraceuticals from the Eastern and Western European regions.
Germany holds a maximum share in the amino-acids, peptides & proteins market of around 23%.
In Europe, there are five major major players in this market: ADM (US), Cargill (US), Kerry Ingredients (US), Ajinomoto (Japan) and others. Kerry Ingredients (US) is the major player with a share of 6%, followed closely by DSM (5.86%).
